Form 4: Saba Capital Management Reduces Stake in BlackRock Capital Allocation Term Trust
SEC Form 4
Saba Capital Management reports selling shares of BlackRock Capital Allocation Term Trust, decreasing its holdings.
Summary
- Saba Capital Management, L.P. reported changes in its beneficial ownership of BlackRock Capital Allocation Term Trust (BCAT) shares.
- On May 8, 2025, Saba Capital sold 72,669 shares at a price of $14.79 per share.
- On May 9, 2025, Saba Capital sold 61,849 shares at a price of $14.83 per share.
- Following these transactions, Saba Capital's indirect beneficial ownership stands at 11,012,618 shares.
Sentiment
Score: 4
Explanation: The sentiment is neutral to slightly negative as a large shareholder is reducing their position, which could be interpreted as a lack of confidence, but it's a common occurrence.
Negatives
- Saba Capital Management reduced its stake in BlackRock Capital Allocation Term Trust.
Industry Context
This filing indicates changes in ownership of a closed-end fund, which is common in the investment management industry. Large shareholders often adjust their positions based on their investment strategies and market conditions.
Key Dates
| Date | Description |
|---|---|
| 05/08/2025 | Saba Capital sold 72,669 shares of BCAT at $14.79 per share. |
| 05/09/2025 | Saba Capital sold 61,849 shares of BCAT at $14.83 per share. |
| 05/12/2025 | Date of signature for the Form 4 filing by Zachary Gindes and Boaz Weinstein. |
Keywords
BlackRock Capital Allocation Term Trust, BCAT, Saba Capital Management, Beneficial Ownership, Share Sale, Form 4
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.